Labyrinthitis and drugs of ingredients of ergoloid mesylates - a phase IV clinical study of FDA data


Labyrinthitis is reported only by a few people who take drugs with ingredients of ergoloid mesylates. This phase IV clinical study analyzes 540 people who have side effects while taking drugs with ingredients of ergoloid mesylates from the the FDA. Among them, 3 have Labyrinthitis. Find out below who they are, when they have Labyrinthitis and more.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Alkergot, Circanol, Deapril-st, Ergoloid mesylates, Gerimal, Hydergine, Hydergine lc, Hydrogenated ergot alkaloids.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 02, 2022

540 people reported to have side effects when taking drugs with ingredients of ergoloid mesylates.
Among them, 3 people (0.56%) have Labyrinthitis

What is Labyrinthitis?

Labyrinthitis (inflammation of the labyrinth or inner ear) is found to be associated with 1,234 drugs and 948 conditions by eHealthMe.

Number of reports submitted per year:

Could drugs with ingredients of ergoloid mesylates cause Labyrinthitis?

Gender of people who have Labyrinthitis when taking drugs with ingredients of ergoloid mesylates *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Labyrinthitis when taking drugs with ingredients of ergoloid mesylates *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Conditions people have *:

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 33.33%
  2. Cerebellar Ischaemia (lack of blood supply to cerebeller): 1 person, 33.33%

Other drugs people take *:

  1. Tegretol: 1 person, 33.33%

Other side effects people have besides Labyrinthitis *:

  1. Meniere's Disease (a disorder of the inner ear that can affect hearing and balance to a varying degree): 1 person, 33.33%
  2. Malaise (a feeling of general discomfort or uneasiness): 1 person, 33.33%
  3. Intestinal Obstruction: 1 person, 33.33%
  4. Headache (pain in head): 1 person, 33.33%
  5. Dizziness: 1 person, 33.33%
  6. Abdominal Pain Upper: 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drugs with ingredients of ergoloid mesylates, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on ergoloid mesylates. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: